Bhatt, Sudhir Valamanesh, Fatemeh Pulpytel, Jérôme Dico, Rea Lo Baiyukha, Aliby Al-dybiat, Iman Marc Pocard Arefi-Khonsari, Farzaneh Mirshahi, Massoud
Published in
Oncotarget
A low pressure plasma process based on plasma deposition has been used todevelop a drug delivery strategy. In this study, a drug delivery system based ondifferent layers of plasma co-polymerized Poly ε-caprolactone-Polyethylene glycol(PCL-PEG) co-polymers was deposited on biocompatible substrates. Cis-platinum(118 μgm/cm2) was used as an anti-cance...
Chen, Lindi Humphreys, Angharad Turnbull, Lisa Bellini, Angela Gudrun Schleiermacher Salwen, Helen Cohn, Susan L. Bown, Nick Tweddle, Deborah A.
Published in
Oncotarget
Anaplastic Lymphoma Kinase (ALK) is a transmembrane receptor kinase that belongs to the insulin receptor superfamily and has previously been shown to play a role in cell proliferation, migration and invasion in neuroblastoma. Activating ALK mutations are reported in both hereditary and sporadic neuroblastoma tumours, and several ALK inhibitors are ...
Vallarelli, Andrelou F Rachakonda, P Sivaramakrishna André, Jocelyne Heidenreich, Barbara Riffaud, Laurence Bensussan, Armand Kumar, Rajiv Dumaz, Nicolas
Published in
Oncotarget
The mechanism of telomerase re-activation in cancer had remained elusive until the discovery of frequent mutations in the promoter of the TERT gene that encodes the catalytic reverse transcriptase subunit of telomerase. We investigated the regulation of TERT expression in melanoma cell lines and our results show that promoter mutations render TERT ...
Merrouche, Yacine Fabre, Joseph Cure, Herve Garbar, Christian Fuselier, Camille Bastid, Jeremy Antonicelli, Frank Al-Daccak, Reem Armand Bensussan Giustiniani, Jerome
...
Published in
Oncotarget
Estrogen receptor-, progesterone receptor- and HER2-negative breast cancers, also known as triple-negative breast cancers (TNBCs), have poor prognoses and are refractory to current therapeutic agents, including epidermal growth factor receptor (EGFR) inhibitors. Resistance to anti-EGFR therapeutic agents is often associated with sustained kinase ph...
Bond, Jonathan Domaschenz, Renae Roman-Trufero, Mónica Sabbattini, Pierangela Ferreiros-Vidal, Isabel Gerrard, Gareth Vahid Asnafi Elizabeth Macintyre Merkenschlager, Matthias Dillon, Niall
...
Published in
Oncotarget
Ikaros and Foxp1 are transcription factors that play key roles in normal lymphopoiesis and lymphoid malignancies. We describe a novel physical and functional interaction between the proteins, which requires the central zinc finger domain of Ikaros. The Ikaros-Foxp1 interaction is abolished by deletion of this region, which corresponds to the IK6 is...
Noé, Gaёlle Bellesoeur, Audrey Thomas-Schoemann, Audrey Rangarajan, Savithri Naji, Faris Puszkiel, Alicja Huillard, Olivier Saidu, Nathaniel Golmard, Lisa Alexandre, Jerome
...
Published in
Oncotarget
Background: Sunitinib is a protein tyrosine kinase (PTK) inhibitor that has immune-modulating properties. In this context, peripheral blood mononuclear cells (PBMC), mainly constituted by lymphocytes, could be a perfect surrogate tissue for identifying and assaying pharmacodynamic biomarkers of sunitinib. In this study, we investigated the changes ...
Beldi-Ferchiou, Asma Lambert, Marion Dogniaux, Stéphanie Vély, Frédéric Vivier, Eric Olive, Daniel Dupuy, Stéphanie Levasseur, Frank Zucman, David Lebbé, Céleste
...
Published in
Oncotarget
Programmed Death-1 (PD-1), an inhibitory receptor expressed by activated lymphocytes, is involved in regulating T- and B-cell responses. PD-1 and its ligands are exploited by a variety of cancers to facilitate tumor escape through PD-1-mediated functional exhaustion of effector T cells. Here, we report that PD-1 is upregulated on Natural Killer (NK...
Romero, Martha Gapihan, Guillaume Castro-Vega, Luis Jaime Acevedo, Andrés Wang, Li Wei Li, Zhao Bouchtaoui, Morad El Benedetto, Mélanie Di Ratajczak, Philippe Feugeas, Jean-Paul
...
Published in
Oncotarget
Background: Primary mediastinal large B-cell lymphoma (PMBL) shares pathological features with diffuse large B-cell lymphoma (DLBCL), and molecular features with classical Hodgkin lymphoma (cHL). The miR-17~92 oncogenic cluster, located at chromosome 13q31, is a region that is amplified in DLBCL.Methods: Here we compared the expression of each memb...
Marçais, Ambroise Waast, Laetitia Bruneau, Julie Hanssens, Katia Vahid Asnafi Gaulard, Philippe Suarez, Felipe Dubreuil, Patrice Gessain, Antoine Olivier Hermine
...
Published in
Oncotarget
Mutations in TET2, encoding one of the TET members responsible for the conversion of DNA cytosine methylation to hydroxymethylation (5-hmc), have been recently described in Human T-lymphotropic virus type 1-associated adult T-cell leukemia/lymphoma (ATLL). However, neither the amount of genomic 5-hmc in ATLL tumor cells nor TET2 expression has been...
Corbineau, Sébastien Lassalle, Bruno Givelet, Maelle Souissi-Sarahoui, Inès Firlej, Virginie Romeo, Paul Riou, Lydia Fouchet, Pierre
Published in
Oncotarget
The male germinal lineage, which is defined as unipotent, produces sperm through spermatogenesis. However, embryonic primordial germ cells and postnatal spermatogonial stem cells (SSCs) can change their fate and convert to pluripotency in culture when they are not controlled by the testicular microenvironment. The mechanisms underlying these reprog...